3 results
Approved WMOCompleted
The objective is to study the effect of beta-agonist and beta-antagonist treatment on human bone remodeling.
Approved WMOCompleted
Primary objective:To determine whether there is a difference in overall survival (OS) between lurbinectedin (PM01183)/doxorubicin (DOX) and a control armconsisting of best Investigator's choice between cyclophosphamide (CTX), doxorubicin (DOX)…
Approved WMOCompleted
To study the potential renoprotective effects of supplementation of alkaline phosphatase in hospitalized patients with AKI